Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of IV Zanamivir in Hospitalized Influenza Patients
NCT01014988Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2009
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of zanamivir in influenza, sponsored by GSK. Started Nov 2009; status: completed.
02
Drugs
zanamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01014988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01014988.